Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesPreferred Dividend PaymentsProfit After TaxRent ExpenseRestructuring CostsRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

National Healthcare Properties (NHPAP) Preferred Dividend Payments (2019 - 2025)

National Healthcare Properties has reported Preferred Dividend Payments over the past 7 years, most recently at $3.3 million for Q4 2025.

  • For Q4 2025, Preferred Dividend Payments fell 4.78% year-over-year to $3.3 million; the TTM value through Dec 2025 reached $13.4 million, down 2.56%, while the annual FY2025 figure was $13.4 million, 2.56% down from the prior year.
  • Preferred Dividend Payments for Q4 2025 was $3.3 million at National Healthcare Properties, down from $3.3 million in the prior quarter.
  • Over five years, Preferred Dividend Payments peaked at $3.4 million in Q1 2022 and troughed at $742000.0 in Q1 2021.
  • A 5-year average of $3.1 million and a median of $3.4 million in 2022 define the central range for Preferred Dividend Payments.
  • Biggest five-year swings in Preferred Dividend Payments: soared 364.96% in 2022 and later decreased 4.78% in 2025.
  • Year by year, Preferred Dividend Payments stood at $3.4 million in 2021, then increased by 2.68% to $3.4 million in 2022, then changed by 0.0% to $3.4 million in 2023, then fell by 0.03% to $3.4 million in 2024, then dropped by 4.78% to $3.3 million in 2025.
  • Business Quant data shows Preferred Dividend Payments for NHPAP at $3.3 million in Q4 2025, $3.3 million in Q3 2025, and $3.4 million in Q2 2025.